Increased susceptibility of a triclabendazole (TCBZ)-resistant isolate of Fasciola hepatica to TCBZ following co-incubation in vitro with the P-glycoprotein inhibitor, R(+)-verapamil.

Parasitology

Volumn 140, Issue 10, 2013, Pages 1287-1303

  Meaney, M ^a   Savage, J ^a   Brennan, G P ^a   Hoey, E ^a   Trudgett, A ^a   Fairweather, I ^a  

^a QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTHELMINTIC AGENT; BENZIMIDAZOLE DERIVATIVE; SULFOXIDE; TRICLABENDAZOLE SULFOXIDE; VERAPAMIL;

ANIMAL; ARTICLE; DRUG EFFECT; DRUG RESISTANCE; FASCIOLA HEPATICA; MALE; RANDOMIZATION; RAT; SCANNING ELECTRON MICROSCOPY; SPRAGUE DAWLEY RAT; ULTRASTRUCTURE;

ANIMALS; ANTHELMINTICS; BENZIMIDAZOLES; DRUG RESISTANCE; FASCIOLA HEPATICA; MALE; MICROSCOPY, ELECTRON, SCANNING; RANDOM ALLOCATION; RATS; RATS, SPRAGUE-DAWLEY; SULFOXIDES; VERAPAMIL;

EID: 84886050607     PISSN: None     EISSN: 14698161     Source Type: Journal    
DOI: 10.1017/S0031182013000759     Document Type: Article

References (0)